[1] |
Rahib L,Smith BD,Aizenberg R,et al.Projecting cancer incidence and deaths to 2030:the unexpected burden of thyroid,liver,and pancreas cancers in the United States[J]. Cancer Res,2014,74(11):2913-2921.
|
[2] |
Endo A.A historical perspective on the discovery of statins[J]. Proc Jpn Acad Ser B Phys Biol Sci,2010,86(5):484-493.
|
[3] |
Kotamaraju S,Williams CL,Kalyanaraman B.Statin-induced breast cancer cell death:role of inducible nitric oxide and arginase-dependent pathways[J].Cancer Res,2012,67(7):7386-7394.
|
[4] |
Yamazaki H,Suzuki M,Aoki T,et al.Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhitors on ubiquinone levels in rat skeletal muscle and heart:relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells[J].J Atheroscler Thromb,2013,13(1):295-307.
|
[5] |
Kah J,Wustenberg A,Keller AD,et al.Selective induction of apoptosis by HMG-GOA reductase inhibitors in hepatoma cells and dependence on p53 expression[J].Oncology,2012,28(3):1077-1083.
|
[6] |
Porfire A,Tomuta I,Muntean D,et al.Optimizing long-circulating liposomes for delivery of simvastatin to colon26 carcinoma cells[J].J Liposome Res,2014,25(4):261-269.
|
[7] |
Yu X,Pan Y,Ma H,et al.Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells[J].Oncol Res,2013,20(8):351-357.
|
[8] |
Spampanato C,Sarnataro M,Giordano E,et al.Simvastatin inhib-its cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of Bcl-2 gene expression[J].Int J Oncol,2012,40(4):935-941.
|
[9] |
Jemal A,Siegel R,Xu J,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5):227-300.
|
[10] |
Heberland J,Bertz J,Wolf U,et al.German cancer statistics 2004[J].BMC Cancer,2010,10:52.
|
[11] |
Li D,Xie K,Wolff R,et al.Pancreatic cancer[J].Lancet,2004,363(9414):1049-1057.
|
[12] |
Rosell R,Carc ereny E,Gervais R,et al.Erlotinib versus standard chemotherapy as first-line treatment for European patie nts with advanced EGFR mutation-positive non-small-cell lung caner(EURTAC):a multicenter,open-label,randomized phase 3 trial[J].Lancet Oncol,2012,13(3):239-246.
|
[14] |
Siegel RL,Miller KD,Jemal A.Cancer statistics[J].CA Cancer J Clin,2015,65(1):5-29.
|
[13] |
Zhou C,Wu YL,Chen G,et al.Erlotinib versus chemotherapy as first-line treatment for pantients with advanced EGFR mutation-positive non-small-cell lung caner(OPTIMAL,CTONG-0802):a multicentre,open-label,randomized,phase 3 study[J].Lancet Oncol,2011,12(8):735-742.
|
[15] |
He Z,Mangala LS,Theriot CA,et al.Cell killling and radio-sensitizing effects of at orvastatin in PC-3prostate cancer cells[J].J Radiat Res,2012,53(2):225-233.
|
[16] |
Martirosyan A,Clendening JW,Goard CA,et al.Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin:potential therapeutic relevance[J].BMC Cancer,2010,10:103.
|